PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
07-Jun-2024 New US headquarters opened by mass photometry pioneers Refeyn Refeyn
07-Jun-2024 PureTech Result of General Meeting PureTech Health plc
07-Jun-2024 iMM Joins the MAGIC Consortium to Advance Research on Muscular Dystrophies The MAGIC Consortium
07-Jun-2024 16th Edition Strategic Partnerships & Portfolio Optimization for Accessible Medicines, Specialty Therapeutics, and Generic Drugs Conference marcus evans
06-Jun-2024 Major cause of inflammatory bowel disease discovered The Francis Crick Institute
06-Jun-2024 Beckman Coulter Life Sciences Releases Innovative Assay to Quantify Antibody Aggregation Beckman Coulter Life Sciences
06-Jun-2024 Clinigen acquires boutique market access consultancy Ascenian to accelerate access to lifesaving treatments Clinigen
06-Jun-2024 KITE RECEIVES EUROPEAN MEDICINES AGENCY APPROVAL OF SAFETY MONITORING VARIATION FOR CAR T-CELL THERAPY PORTFOLIO Gilead Sciences
06-Jun-2024 Alchemab advances a novel antibody with potential in Parkinson’s disease with support from The Michael J. Fox Foundation Alchemab
06-Jun-2024 CYCLE PHARMACEUTICALS ANNOUNCES ALL-CASH PROPOSAL TO ACQUIRE VANDA PHARMACEUTICALS FOR $8.00 PER SHARE Cycle Pharmaceuticals
06-Jun-2024 FDA and CluePoints Sign New 3 Year Cooperative Research and Development Agreement to Assess Data Quality using Statistical Modelling and Machine Learning CluePoints
05-Jun-2024 OrganaBio expands California CPC Services hub for sample processing and cryopreservation capabilities to support Big Pharma clinical trials OrganaBio
05-Jun-2024 Celerion Honored With Prestigious CRO Leadership Award for Ninth Consecutive Year Celerion
05-Jun-2024 Nobel Laureate Professor Sir Martin Evans opens Molecular Devices’ Cardiff facility to manufacture patient-derived organoids for research and drug discovery Molecular Devices, LLC.
05-Jun-2024 Quell Therapeutics Advances QEL-001, its Multi-modular Engineered CAR-Treg Cell Therapy, into Efficacy Cohort of LIBERATE Phase 1/2 Trial in Liver Transplant Patients Quell Therapeutics
05-Jun-2024 OncoZenge participates in MASCC cancer care conference June 27-29 OncoZenge
05-Jun-2024 Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine Valneva SE
05-Jun-2024 Grey Wolf Therapeutics Presents First Clinical Data for GRWD5769, a First-in-Class ERAP1 Inhibitor, at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting Grey Wolf Therapeutics
05-Jun-2024 Otsuka announces new results from OASIS-HAE and OASISplus studies of investigational medicine donidalorsen in people with hereditary angioedema Otsuka Pharmaceutical Europe Ltd.
05-Jun-2024 Aragen Bioscience Validates Getinge's Single-Use Production Reactor (SUPR) Aragen